India · Delayed Price · Currency is INR Sanofi India Company Description
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors.
It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012.
The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
| Country | India |
| Founded | 1956 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,225 |
| CEO | Rodolfo Hrosz |
Contact Details
Address: Sanofi House Mumbai, 400072 India | |
| Phone | 91 22 2803 2000 |
| Website | sanofi.com |
Stock Details
| Ticker Symbol | 500674 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rodolfo Hrosz | Chief Executive Officer |
| Rachid Ayari | Chief Financial Officer |